Severe Hemophilia A Withdrawn Phase 3 Trials for Emicizumab (DB13923)

Also known as: Severe Haemophilia A / Hemophilia A, Severe

IndicationStatusPhase
DBCOND0034640 (Severe Hemophilia A)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02196207Hemophilia Inhibitor Clinical Trials (INHIBIT) PlatformTreatment